Personalisto Present New Data at the AACR Tumor Immunology and Immunotherapy Conference

Personalis, Inc. (NASDAQ: PSNL) today announced that the company will participate in the AACR Tumor Immunology and Immunotherapy conference at the Boston Marriott Copley Place in Boston, MA, November 17-20, including poster presentations on November 18th and 1

Benzinga · 11/18/2019 00:48

Personalis, Inc. (NASDAQ: PSNL) today announced that the company will participate in the AACR Tumor Immunology and Immunotherapy conference at the Boston Marriott Copley Place in Boston, MA, November 17-20, including poster presentations on November 18th and 19th.

The company will showcase ImmunoID NeXT™, the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. ImmunoID NeXT™ can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.

Following is a list of abstracts that will be presented at the meeting.

Scientific Poster Presentations

Poster Number

Title & Presenter

Day & Time

Location

A19

HLA allele-specific loss of heterozygosity detection

using augmented exome capture approach

Presenter: Rachel Marty Pyke, Ph.D.

November 18:

12:30 PM – 3:00 PM

Back Bay

B18

Exome scale liquid biopsy monitoring of putative

neoantigens and genomic biomarkers in patients

on anti-PD-1 therapy in squamous cell carcinoma of

the head and neck

Presenter: Charles Abbott, Ph.D.

November 19:

4:30 PM – 7:00 PM

Back Bay

Personalis will also be exhibiting during the conference (Exhibit # 10). Representatives will be available to answer questions about the company's cancer immunogenomics services.